Huons said Wednesday that it has appointed Vice President Park Kyung-mi to head its new growth R&D business.

Park graduated from Seoul National University's Department of Pharmaceutical Sciences and earned her Ph.D. from the Graduate School of Pharmacy of the same university where she majored in physical pharmacy.

After earning her doctorate, Park served as the clinical manager of the development team at CJ Pharmaceutical Business Division, director of the clinical team at Hanmi Pharmaceutical, executive director of the development department at CHA Biotech, senior vice president of product development at Chong Kun Dang’s Development Center, and vice president of R&D at Genome & Company.

She has also served as a member of the Clinical Development Committee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), the Project Evaluation and Investment Review Committee of the Korea Drug Development Fund, and most recently, the Investment Review Committee of the KDDF and the R&D Committee of the Korea Industry Pharmacists Association.

“Over the past 27 years since earning her Ph.D., Park has established a reputation as a clinical development expert in pharmaceutical companies and biotechs,” a Huons official said. “With her wealth of experience across the entire process from clinical development planning to approval and sales, she is the right person to accelerate Huons’ long-term growth momentum.”